An RT-PCR study of 5-HT6 and 5-HT7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia

被引:50
作者
East, SZ
Burnet, PWJ
Kerwin, RW
Harrison, PJ
机构
[1] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
[2] Inst Psychiat, Sect Clin Neuropharmacol, London, England
关键词
5-hydroxytryptamine (5-HT); serotonin-6; serotonin-7; human brain; neuroleptic; psychosis;
D O I
10.1016/S0920-9964(01)00323-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
5-Hydroxytryptamine (5-HT; serotonin) 5-HT6 receptors (5-HT6R) and 5-HT7 receptors (5-HT7R) have been implicated in schizophrenia and as targets of atypical antipsychotic drugs. We have studied the expression of these receptors in the hippocampal formation and dorsolateral prefrontal cortex (DLPFC) of 17 subjects with schizophrenia and 17 controls using reverse transcription-polymerase chain reaction (RT-PCR) with cyclophilin co-amplification. In schizophrenia, 5-HT6R mRNA was decreased in the hippocampal formation, and 5-HT7R mRNA was decreased in the dorsolateral prefrontal cortex. The mRNAs were unchanged in rats treated for 2 weeks with haloperidol, chlorpromazine, risperidone, olanzapine or clozapine. Regional decreases in 5-HT6R and 5-HT7R expression in schizophrenia may contribute to the overall serotonergic alterations which occur in the disorder, in part through their interactions with other neurotransmitter systems including glutamate and acetylcholine. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:15 / 26
页数:12
相关论文
共 81 条
[1]   Serotonin-glutamate interactions: A new target for antipsychotic drugs [J].
Aghajanian, GK ;
Marek, GJ .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) :S122-S133
[2]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[3]   Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response [J].
Arranz, MJ ;
Munro, J ;
Sham, P ;
Kirov, G ;
Murray, RM ;
Collier, DA ;
Kerwin, RS .
SCHIZOPHRENIA RESEARCH, 1998, 32 (02) :93-99
[4]  
BARD JA, 1993, J BIOL CHEM, V268, P23422
[5]  
BENES F, 2001, IN PRESS
[6]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[7]   The 5-hydroxytryptamine, receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum [J].
Boess, FG ;
Riemer, C ;
Bös, M ;
Bentley, J ;
Bourson, A ;
Sleight, AJ .
MOLECULAR PHARMACOLOGY, 1998, 54 (03) :577-583
[8]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[9]   5-HT6 receptors as emerging targets for drug discovery [J].
Branchek, TA ;
Blackburn, TP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :319-334
[10]   5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia [J].
Burnet, PWJ ;
Eastwood, SL ;
Harrison, PJ .
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (05) :442-455